TAI-95 is an orally active inhibitor of the mitotic regulator Hec1 (Highly expressed in cancer protein 1); it blocks the interaction between Hec1 and NEK2, exhibits cytotoxicity in human hepatocellular carcinoma cells (GI50 = 15–70 nM), induces apoptosis in Huh-7 cells, and demonstrates antitumor activity in mouse models.